1. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. (24th February 2022) Authors: Crijns, Harry J.G.M.; Elvan, Arif; Al-Windy, Nadea; Tuininga, Ype S.; Badings, Erik; Aksoy, Ismail; Van Gelder, Isabelle C.; Madhavapeddi, Prashanti; Camm, A. John; Kowey, Peter R.; Ruskin, Jeremy N.; Belardinelli, Luiz Journal: Circulation Issue: Volume 15:Number 3(2022) Page Start: e010204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. (March 2022) Authors: Crijns, Harry J.G.M.; Elvan, Arif; Al-Windy, Nadea; Tuininga, Ype S.; Badings, Erik; Aksoy, Ismail; Van Gelder, Isabelle C.; Madhavapeddi, Prashanti; Camm, A. John; Kowey, Peter R.; Ruskin, Jeremy N.; Belardinelli, Luiz Journal: Circulation Issue: Volume 15:Number 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗